The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
Open accessAbstract
Viral infections kill millions yearly. Available antiviral drugs are virus-specific and active against a limited panel of human pathogens. There are broad-spectrum substances that prevent the first step of virus-cell interaction by mimicking heparan sulfate proteoglycans (HSPG), the highly conserved target of viral attachment ligands (VALs). The reversible binding mechanism prevents their use as a drug, because, upon dilution, the inhibition is lost. Known VALs are made of closely packed repeating units, but the aforementioned substances are able to bind only a few of them. We designed antiviral nanoparticles with long and flexible linkers mimicking HSPG, allowing for effective viral association with a binding that we simulate to be strong and multivalent to the VAL repeating units, generating forces (∼190 pN) that eventually lead to irreversible viral deformation. Virucidal assays, electron microscopy images, and molecular dynamics simulations support the proposed mechanism. These particles show no cytotoxicity, and in vitro nanomolar irreversible activity against herpes simplex virus (HSV), human papilloma virus, respiratory syncytial virus (RSV), dengue and lenti virus. They are active ex vivo in human cervicovaginal histocultures infected by HSV-2 and in vivo in mice infected with RSV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.-S., Watson, N., Chen, S., Irvine, D. J., & Stellacci, F. (2008) · Nature Materials · doi:10.1038/nmat2202 · Cited by 1,266
Self-citationSilver nanoparticles are broad-spectrum bactericidal and virucidal compounds
Lara, H. H., Garza-Treviño, E. N., Ixtepan-Turrent, L., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-30 · Cited by 741
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
A general mechanism for intracellular toxicity of metal-containing nanoparticles
Sabella, S., Carney, R. P., Brunetti, V., Malvindi, M. A., Al-Juffali, N., Vecchio, G., Janes, S. M., Bakr, O. M., Cingolani, R., Stellacci, F., et al. (2014) · Nanoscale · doi:10.1039/c4nr01234h · Cited by 467
Self-citationLack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
Van Damme, L., Govinden, R., Mirembe, F. M., Guédou, F., Solomon, S., Becker, M. L., Pradeep, B. S., Krishnan, A. K., Alary, M., Pande, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707957 · Cited by 438
1-Anilino-8-Naphthalene Sulfonate Anion-Protein Binding Depends Primarily on Ion Pair Formation
Matulis, D., & Lovrien, R. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77799-9 · Cited by 405
Inhibition of HIV Fusion with Multivalent Gold Nanoparticles
Bowman, M.-C., Ballard, T. E., Ackerson, C. J., Feldheim, D. L., Margolis, D. M., & Melander, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710321g · Cited by 371
McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61086-0 · Cited by 335
Self-citationThe complex nature of calcium cation interactions with phospholipid bilayers
Melcrová, A., Pokorna, S., Pullanchery, S., Kohagen, M., Jurkiewicz, P., Hof, M., Jungwirth, P., Cremer, P. S., & Cwiklik, L. (2016) · Scientific Reports · doi:10.1038/srep38035 · Cited by 289
Vesicles in contact with nanoparticles and colloids
Lipowsky, R., & Döbereiner, H.-G. (1998) · Europhysics Letters (EPL) · doi:10.1209/epl/i1998-00343-4 · Cited by 243
Baram‐Pinto, D., Shukla, S., Gedanken, A., & Sarid, R. (2010) · Small · doi:10.1002/smll.200902384 · Cited by 237
Qian, E. A., Wixtrom, A. I., Axtell, J. C., Saebi, A., Jung, D., Rehak, P., Han, Y., Moully, E. H., Mosallaei, D., Chow, S., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2686 · Cited by 224
Self-citationPathogen Inhibition by Multivalent Ligand Architectures
Bhatia, S., Camacho, L. C., & Haag, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12950 · Cited by 194
Heparan sulfate: Anchor for viral intruders?
Spillmann, D. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01290-1 · Cited by 181
Visualizing the replication of respiratory syncytial virus in cells and in living mice
Rameix‐Welti, M., Goffic, R. L., Hervé, P., Sourimant, J., Rémot, A., Riffault, S., Yu, Q., Galloux, M., Gault, E., & Eléouët, J. (2014) · Nature Communications · doi:10.1038/ncomms6104 · Cited by 172
Self-citationHuang, R., Carney, R. P., Ikuma, K., Stellacci, F., & Lau, B. L. T. (2014) · ACS Nano · doi:10.1021/nn501203k · Cited by 157
Self-citationKnappe, M., Bodevin, S., Selinka, H., Spillmann, D., Streeck, R. E., Chen, X. S., Lindahl, U., & Sapp, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705127200 · Cited by 139
Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro
Chen, N., Zheng, Y., Yin, J., Li, X., & 郑丛龙 (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.07.020 · Cited by 133
The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1
Pirrone, V., Wigdahl, B. L., & Krebs, F. C. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.03.176 · Cited by 124
Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus
Dasgupta, J., Bienkowska‐Haba, M., Ortega, M. E., Patel, H. D., Bodevin, S., Spillmann, D., Bishop, B., Sapp, M. J., & Chen, X. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160184 · Cited by 113
Riblett, A. M., Blomen, V. A., Jae, L. T., Altamura, L. A., Doms, R. W., Brummelkamp, T. R., & Wojcechowskyj, J. A. (2015) · Journal of Virology · doi:10.1128/jvi.02055-15 · Cited by 111
Viral Inhibition Mechanism Mediated by Surface-Modified Silica Nanoparticles
Silva, J. M. D. S. E., Melo‐Hanchuk, T. D., Santos, M. I., Kobarg, J., Bajgelman, M. C., & Cardoso, M. B. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03342 · Cited by 100
Rusnati, M., Vicenzi, E., Donalisio, M., Oreste, P., Landolfo, S., & Lembo, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.001 · Cited by 91
Self-citationThe effect of interactions on the cellular uptake of nanoparticles
Chaudhuri, A., Battaglia, G., & Golestanian, R. (2011) · Physical Biology · doi:10.1088/1478-3975/8/4/046002 · Cited by 84
The effect of interactions on the cellular uptake of nanoparticles
Chaudhuri, A., Battaglia, G., & Golestanian, R. (2011) · UCL Discovery (University College London) · Cited by 80
Klimyte, E. M., Smith, S. E., Oreste, P., Lembo, D., & Dutch, R. (2016) · Journal of Virology · doi:10.1128/jvi.01362-16 · Cited by 64
Self-citationShogan, B. D., Kruse, L., Mulamba, G. B., Hu, A., & Coen, D. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4740-4747.2006 · Cited by 45
Lembo, D., Donalisio, M., Laine, C., Cagno, V., Civra, A., Bianchini, E. P., Zeghbib, N., & Bouchemal, K. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.007 · Cited by 40
Self-citationBromberg, L. E., Bromberg, D. J., Hatton, T. A., Bandín, I., Concheiro, Á., & Alvarez‐Lorenzo, C. (2012) · Langmuir · doi:10.1021/la205127x · Cited by 39
Donalisio, M., Quaranta, P., Chiuppesi, F., Pistello, M., Cagno, V., Cavalli, R., Volante, M., Bugatti, A., Rusnati, M., Ranucci, E., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.055 · Cited by 35
Self-citation
Cited by
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 659
Enantiomer-dependent immunological response to chiral nanoparticles
Xu, L., Wang, X., Wang, W., Sun, M., Choi, W. J., Kim, J.-Y., Hao, C., Li, S., Qu, A., Lu, M., et al. (2022) · Nature · doi:10.1038/s41586-021-04243-2 · Cited by 641
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiss, C., Carriere, M., Fusco, L., Capua, I., Regla-Nava, J. A., Pasquali, M., Scott, J. A., Vitale, F., Unal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 601
Self-citationHuang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Imani, S. M., Ladouceur, L., Marshall, T., Maclachlan, R., Soleymani, L., & Didar, T. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c05937 · Cited by 433
Metadata
- Authors
- Cagno, V., Andreozzi, P., D’Alicarnasso, M., Jacob Silva, P., Mueller, M., Galloux, M., Le Goffic, R., Jones, S. T., Vallino, M., Hodek, J., Weber, J., Sen, S., Janeček, E.-R., Bekdemir, A., Sanavio, B., Martinelli, C., Donalisio, M., Rameix Welti, M.-A., Eleouet, J.-F., Han, Y., Kaiser, L., Vukovic, L., Tapparel, C., Král, P., Krol, S., Lembo, D., & Stellacci, F.
- Venue
- Nature Materials
- Published
- 2017-12-18
- Volume
- 17
- Issue
- 2
- Pages
- 195-203
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W2779102422
- Cited by
- 428
- References
- 33
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.